Literature DB >> 25332618

Remission of microangiopathy in transplanted thalassemic child.

Priya Marwah1, Rajpreet Soni1, Lawrence Faulkner2, Mohammed El Missiry2, Cornelio Uderzo2.   

Abstract

Transplant associated thrombotic microangiopathy is a severe complication of Hematopoeitic stem cell transplantation. Although there is agreement in terms of diagnostic criteria, treatment options are not clarified yet. We present a patient aged 2.6 years who developed transplant associated thrombotic microangiopathy after allogeneic bone marrow transplantation and to discuss both risk factors and possible spontaneous remission of transplant associated thrombotic microangiopathy.

Entities:  

Keywords:  CMV infection; Cyclosporine; Microangiopathy; Transplantation

Year:  2014        PMID： 25332618      PMCID： PMC4192246          DOI： 10.1007/s12288-014-0404-2

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


  17 in total

Review 1.  Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

Authors:  Benjamin L Laskin; Jens Goebel; Stella M Davies; Sonata Jodele
Journal:  Blood       Date:  2011-05-19       Impact factor: 22.113

Review 2.  Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation.

Authors:  C Uderzo; M Fumagalli; P De Lorenzo; A Busca; E Vassallo; S Bonanomi; E Lanino; G Dini; S Varotto; C Messina; R Miniero; M G Valsecchi; A Balduzzi
Journal:  Bone Marrow Transplant       Date:  2000-11       Impact factor: 5.483

Review 3.  Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation.

Authors:  Vincent T Ho; Corey Cutler; Shelly Carter; Paul Martin; Roberta Adams; Mary Horowitz; James Ferrara; Robert Soiffer; Sergio Giralt
Journal:  Biol Blood Marrow Transplant       Date:  2005-08       Impact factor: 5.742

4.  Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease.

Authors:  D Wolff; S Wilhelm; J Hahn; C Gentilini; I Hilgendorf; B Steiner; C Kahl; C Junghanss; G Hartung; J Casper; L Uharek; E Holler; M Freund
Journal:  Bone Marrow Transplant       Date:  2006-09       Impact factor: 5.483

5.  Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab.

Authors:  Wing-Yan Au; Edmond S Ma; Tsz-Leung Lee; Shau-Yin Ha; Alvin T Fung; Albert K W Lie; Yok-Lam Kwong
Journal:  Br J Haematol       Date:  2007-04-13       Impact factor: 6.998

6.  Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.

Authors:  Corey Cutler; N Lynn Henry; Colm Magee; Shuli Li; Haesook T Kim; Edwin Alyea; Vincent Ho; Stephanie J Lee; Robert Soiffer; Joseph H Antin
Journal:  Biol Blood Marrow Transplant       Date:  2005-07       Impact factor: 5.742

7.  Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation.

Authors:  Byung-Sik Cho; Seung-Ah Yahng; Sung-Eun Lee; Ki-Seong Eom; Yoo-Jin Kim; Hee-Je Kim; Seok Lee; Chang-Ki Min; Seok-Goo Cho; Dong-Wook Kim; Jong-Wook Lee; Woo-Sung Min; Chong-Won Park
Journal:  Transplantation       Date:  2010-10-27       Impact factor: 4.939

8.  Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced.

Authors:  Avichai Shimoni; Moshe Yeshurun; Izhar Hardan; Abraham Avigdor; Isaac Ben-Bassat; Arnon Nagler
Journal:  Biol Blood Marrow Transplant       Date:  2004-07       Impact factor: 5.742

9.  Intravenous immunoglobulin as an adjunct to plasma exchange for the treatment of chronic thrombotic thrombocytopenic purpura.

Authors:  J C Moore; D M Arnold; B F Leber; R Clare; G J Molnar; J G Kelton
Journal:  Vox Sang       Date:  2007-08       Impact factor: 2.144

10.  Thrombotic microangiopathy in haematopoietic cell transplantation: an update.

Authors:  Evi Stavrou; Hillard M Lazarus
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-11-03       Impact factor: 2.576
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.